Across TCGA pan-cancer cohorts, MIR203A RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of MIR203A’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where MIR203A RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR203A is over-expressed in tumor, although a few such as THCA and LIHC show the opposite, repressed pattern.

LUSC, COAD, and THCA are the cancer types where MIR203A tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR203A RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	Male	All	+0.403	<.001	4	view →
COAD	All	All	+0.198	.017	3	view →
THCA	Female	All	−0.134	.031	2	view →
LIHC	All	II,III,IV	−0.087	.040	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: MIR203A RNA expression & survival · all MIR203A data types